Researchers at MIT have unveiled a way to temporarily reboot aging immune systems, using a targeted mRNA therapy that turns the liver into a short‑lived factory for powerful T‑cell survival signals.

MILAN and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a pioneer in immuno-oncology, today announced that a total of 38 patients were enrolled in newly diagnosed glioblastoma ...